SINGLOMICS
Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
SINGLOMICS
Industry:
Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.singlomics.com
Status:
Active
Contact:
010-80765087
Email Addresses:
[email protected]
Total Funding:
47.16 M USD
Technology used in webpage:
SPF HiChina DNS
Current Employees Featured
Founder
Investors List
Tencent
Tencent investment in Venture Round - Singlomics
Huagai Capital
Huagai Capital investment in Series B - Singlomics
BOHE Angel Fund
BOHE Angel Fund investment in Series B - Singlomics
MSA Capital
MSA Capital investment in Series B - Singlomics
JIANYI CAPITAL
JIANYI CAPITAL investment in Series B - Singlomics
Legend Capital
Legend Capital investment in Series B - Singlomics
GL Ventures
GL Ventures investment in Series B - Singlomics
Witruth Capital
Witruth Capital investment in Series B - Singlomics
Founder H Fund
Founder H Fund investment in Series B - Singlomics
CASH Capital
CASH Capital investment in Series B - Singlomics
Official Site Inspections
http://www.singlomics.com
- Host name: 61.160.192.102
- IP address: 61.160.192.102
- Location: China
- Latitude: 32.0617
- Longitude: 118.7778
- Timezone: Asia/Shanghai
More informations about "Singlomics"
singlomics.com - 丹序生物-关于丹序
北京丹序生物制药有限公司是一家致力于利用单细胞测序技术，针对肿瘤、炎症和自免性疾病等适应症进行抗体药物研发的生物技术公司。丹序生物建成了从抗原免疫、单B细胞抗体发现、DMS …See details»
Singlomics - Crunchbase Company Profile & Funding
Singlomics uses single-cell sequencing technology for antibody drug discovery.See details»
Singlomics Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Singlomics. Use the PitchBook Platform to explore the full profile.See details»
Singlomics - Funding, Financials, Valuation & Investors
Singlomics uses single-cell sequencing technology for antibody drug discovery.See details»
SINGLOMICS - Company Profile - Tracxn
Jan 9, 2025 SINGLOMICS - Developer of therapeutics to treat infectious diseases and cancer. Raised funding over 1 round from 9 investors.See details»
Singlomics - Contacts, Employees, Board Members, Advisors
Singlomics uses single-cell sequencing technology for antibody drug discovery.See details»
Singulomics Corporation - LinkedIn
Singulomics, established in New York in 2016, is a privately-held biotechnology company that aims to transform single-cell omics research and unlock its many applications in biology and …See details»
Singlomics Biopharmaceuticals - Products, Competitors, Financials ...
About Singlomics Biopharmaceuticals Singlomics Biopharmaceuticals is committed to using its single-cell sequencing technology platform for research and development of antibody drugs, …See details»
Beijing Danxu Biopharmaceutical Co., Ltd.
了解Beijing Danxu Biopharmaceutical Co., Ltd. (北京丹序生物制药有限公司)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:感染，肿瘤，免疫系统疾病，技术平台:单克隆抗 …See details»
丹序生物-公司新闻 - singlomics.com
北京丹序生物制药有限公司（Singlomics Biopharmaceuticals，简称：丹序生物）近日宣布已完成近1亿元A轮人民币融资。 本轮融资由高瓴创投、华盖资本联合领投，北京昌发展、首发展、 …See details»
丹序生物任命施前博士为首席执行官（CEO）
公司的两个产品管线DXP593和DXP604，是从康复的COVID-19患者体内使用单细胞测序技术平台筛选出的具有中和能力的单克隆抗体。 目前正处于临床开发阶段，用于COVID-19的治疗和预防。 丹序生物联系方式： 曾女士 …See details»
Singlomics - Golden
Singlomics is a Beijing-based company founded in 2020 by Xiaoliang Sunney Xie.See details»
Document - SEC.gov
Singlomics (Beijing DanXu) Biopharmaceuticals is a biotech company focusing on antibody drug discovery and development utilizing its world-leading single cell sequencing platforms. It aims …See details»
Singlomics - Tech Stack, Apps, Patents & Trademarks
Jan 13, 2025 Singlomics uses single-cell sequencing technology for antibody drug discovery.See details»
Expert Single-Cell Sequencing Service in NY | Singulomics …
Single-cell RNA-Seq enables the study of cell-to-cell transcriptome heterogeneity, which opens a new field in biology. Singulomics Corporation is highly experienced in a high-throughput single …See details»
丹序生物-科学与研发 - singlomics.com
丹序生物建成了从抗原免疫、单B细胞抗体发现、DMS抗体筛选到AI抗体工程一体化的抗体开发平台，可实现抗体类药物的高质量、高通量和高效率的快速研发。See details»
Singlomics - Crunchbase
Singlomics uses single-cell sequencing technology for antibody drug discovery.See details»
Singulomics - Crunchbase Company Profile & Funding
Singulomics Corporation offers single-cell RNA sequencing and analysis services in biotechnology.See details»
Singlomics Completes CNY 300 Million Series B to Develop COVID …
Singlomics Biopharmaceuticals is an innovative drug company dedicated to research and development of antibody drugs using single-cell sequencing technology platform, focusing on …See details»
Series B - Singlomics - 2022-02-02 - Crunchbase Funding Round …
Feb 2, 2022 Singlomics raised $47162396 on 2022-02-02 in Series BSee details»